Author Correction: 6-month follow-up of VIALE-C demonstrates improved and durable efficacy in patients with untreated AML ineligible for intensive chemotherapy

Gespeichert in:

Autor*in:	Andrew H. Wei [verfasserIn] Panayiotis Panayiotidis [verfasserIn] Pau Montesinos [verfasserIn] Kamel Laribi [verfasserIn] Vladimir Ivanov [verfasserIn] Inho Kim [verfasserIn] Jan Novak [verfasserIn] Don A. Stevens [verfasserIn] Walter Fiedler [verfasserIn] Maria Pagoni [verfasserIn] Julie Bergeron [verfasserIn] Stephen B. Ting [verfasserIn] Jing-Zhou Hou [verfasserIn] Achilles Anagnostopoulos [verfasserIn] Andrew McDonald [verfasserIn] Vidhya Murthy [verfasserIn] Takahiro Yamauchi [verfasserIn] Jianxiang Wang [verfasserIn] Brenda Chyla [verfasserIn] Yan Sun [verfasserIn] Qi Jiang [verfasserIn] Wellington Mendes [verfasserIn] John Hayslip [verfasserIn] Courtney D. DiNardo [verfasserIn]

Format:	E-Artikel
Sprache:	Englisch

Erschienen:	2021

Übergeordnetes Werk:	In: Blood Cancer Journal - Nature Publishing Group, 2012, 11(2021), 10, Seite 1
Übergeordnetes Werk:	volume:11 ; year:2021 ; number:10 ; pages:1

Links:	Link aufrufen Link aufrufen Link aufrufen Journal toc

DOI / URN:	10.1038/s41408-021-00565-6

Katalog-ID:	DOAJ076147053

Internformat


LEADER	01000caa a22002652 4500
001	DOAJ076147053
003	DE-627
005	20230503061947.0
007	cr uuu---uuuuu
008	230228s2021 xx \|\|\|\|\|o 00\| \|\|eng c
024	7		\|a 10.1038/s41408-021-00565-6 \|2 doi
035			\|a (DE-627)DOAJ076147053
035			\|a (DE-599)DOAJb2dcda724d79402f9d0cb3d910620b7a
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a eng
050		0	\|a RC254-282
100	0		\|a Andrew H. Wei \|e verfasserin \|4 aut
245	1	0	\|a Author Correction: 6-month follow-up of VIALE-C demonstrates improved and durable efficacy in patients with untreated AML ineligible for intensive chemotherapy
264		1	\|c 2021
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
653		0	\|a Neoplasms. Tumors. Oncology. Including cancer and carcinogens
700	0		\|a Panayiotis Panayiotidis \|e verfasserin \|4 aut
700	0		\|a Pau Montesinos \|e verfasserin \|4 aut
700	0		\|a Kamel Laribi \|e verfasserin \|4 aut
700	0		\|a Vladimir Ivanov \|e verfasserin \|4 aut
700	0		\|a Inho Kim \|e verfasserin \|4 aut
700	0		\|a Jan Novak \|e verfasserin \|4 aut
700	0		\|a Don A. Stevens \|e verfasserin \|4 aut
700	0		\|a Walter Fiedler \|e verfasserin \|4 aut
700	0		\|a Maria Pagoni \|e verfasserin \|4 aut
700	0		\|a Julie Bergeron \|e verfasserin \|4 aut
700	0		\|a Stephen B. Ting \|e verfasserin \|4 aut
700	0		\|a Jing-Zhou Hou \|e verfasserin \|4 aut
700	0		\|a Achilles Anagnostopoulos \|e verfasserin \|4 aut
700	0		\|a Andrew McDonald \|e verfasserin \|4 aut
700	0		\|a Vidhya Murthy \|e verfasserin \|4 aut
700	0		\|a Takahiro Yamauchi \|e verfasserin \|4 aut
700	0		\|a Jianxiang Wang \|e verfasserin \|4 aut
700	0		\|a Brenda Chyla \|e verfasserin \|4 aut
700	0		\|a Yan Sun \|e verfasserin \|4 aut
700	0		\|a Qi Jiang \|e verfasserin \|4 aut
700	0		\|a Wellington Mendes \|e verfasserin \|4 aut
700	0		\|a John Hayslip \|e verfasserin \|4 aut
700	0		\|a Courtney D. DiNardo \|e verfasserin \|4 aut
773	0	8	\|i In \|t Blood Cancer Journal \|d Nature Publishing Group, 2012 \|g 11(2021), 10, Seite 1 \|w (DE-627)655134174 \|w (DE-600)2600560-8 \|x 20445385 \|7 nnns
773	1	8	\|g volume:11 \|g year:2021 \|g number:10 \|g pages:1
856	4	0	\|u https://doi.org/10.1038/s41408-021-00565-6 \|z kostenfrei
856	4	0	\|u https://doaj.org/article/b2dcda724d79402f9d0cb3d910620b7a \|z kostenfrei
856	4	0	\|u https://doi.org/10.1038/s41408-021-00565-6 \|z kostenfrei
856	4	2	\|u https://doaj.org/toc/2044-5385 \|y Journal toc \|z kostenfrei
912			\|a GBV_USEFLAG_A
912			\|a SYSFLAG_A
912			\|a GBV_DOAJ
912			\|a SSG-OLC-PHA
912			\|a GBV_ILN_20
912			\|a GBV_ILN_22
912			\|a GBV_ILN_23
912			\|a GBV_ILN_24
912			\|a GBV_ILN_31
912			\|a GBV_ILN_39
912			\|a GBV_ILN_40
912			\|a GBV_ILN_60
912			\|a GBV_ILN_62
912			\|a GBV_ILN_63
912			\|a GBV_ILN_65
912			\|a GBV_ILN_69
912			\|a GBV_ILN_73
912			\|a GBV_ILN_74
912			\|a GBV_ILN_95
912			\|a GBV_ILN_105
912			\|a GBV_ILN_110
912			\|a GBV_ILN_151
912			\|a GBV_ILN_161
912			\|a GBV_ILN_170
912			\|a GBV_ILN_206
912			\|a GBV_ILN_213
912			\|a GBV_ILN_230
912			\|a GBV_ILN_285
912			\|a GBV_ILN_293
912			\|a GBV_ILN_602
912			\|a GBV_ILN_2014
912			\|a GBV_ILN_4012
912			\|a GBV_ILN_4037
912			\|a GBV_ILN_4112
912			\|a GBV_ILN_4125
912			\|a GBV_ILN_4126
912			\|a GBV_ILN_4249
912			\|a GBV_ILN_4305
912			\|a GBV_ILN_4306
912			\|a GBV_ILN_4307
912			\|a GBV_ILN_4313
912			\|a GBV_ILN_4322
912			\|a GBV_ILN_4323
912			\|a GBV_ILN_4324
912			\|a GBV_ILN_4325
912			\|a GBV_ILN_4338
912			\|a GBV_ILN_4367
912			\|a GBV_ILN_4700
951			\|a AR
952			\|d 11 \|j 2021 \|e 10 \|h 1

Indexfelder

author_variant	a h w ahw p p pp p m pm k l kl v i vi i k ik j n jn d a s das w f wf m p mp j b jb s b t sbt j z h jzh a a aa a m am v m vm t y ty j w jw b c bc y s ys q j qj w m wm j h jh c d d cdd
matchkey_str	article:20445385:2021----::uhrorcinmnholwpfilceosrtsmrvdndrbefiaynainsihnraeal
hierarchy_sort_str	2021
callnumber-subject-code	RC
publishDate	2021
allfields	10.1038/s41408-021-00565-6 doi (DE-627)DOAJ076147053 (DE-599)DOAJb2dcda724d79402f9d0cb3d910620b7a DE-627 ger DE-627 rakwb eng RC254-282 Andrew H. Wei verfasserin aut Author Correction: 6-month follow-up of VIALE-C demonstrates improved and durable efficacy in patients with untreated AML ineligible for intensive chemotherapy 2021 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Neoplasms. Tumors. Oncology. Including cancer and carcinogens Panayiotis Panayiotidis verfasserin aut Pau Montesinos verfasserin aut Kamel Laribi verfasserin aut Vladimir Ivanov verfasserin aut Inho Kim verfasserin aut Jan Novak verfasserin aut Don A. Stevens verfasserin aut Walter Fiedler verfasserin aut Maria Pagoni verfasserin aut Julie Bergeron verfasserin aut Stephen B. Ting verfasserin aut Jing-Zhou Hou verfasserin aut Achilles Anagnostopoulos verfasserin aut Andrew McDonald verfasserin aut Vidhya Murthy verfasserin aut Takahiro Yamauchi verfasserin aut Jianxiang Wang verfasserin aut Brenda Chyla verfasserin aut Yan Sun verfasserin aut Qi Jiang verfasserin aut Wellington Mendes verfasserin aut John Hayslip verfasserin aut Courtney D. DiNardo verfasserin aut In Blood Cancer Journal Nature Publishing Group, 2012 11(2021), 10, Seite 1 (DE-627)655134174 (DE-600)2600560-8 20445385 nnns volume:11 year:2021 number:10 pages:1 https://doi.org/10.1038/s41408-021-00565-6 kostenfrei https://doaj.org/article/b2dcda724d79402f9d0cb3d910620b7a kostenfrei https://doi.org/10.1038/s41408-021-00565-6 kostenfrei https://doaj.org/toc/2044-5385 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ SSG-OLC-PHA GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 11 2021 10 1
spelling	10.1038/s41408-021-00565-6 doi (DE-627)DOAJ076147053 (DE-599)DOAJb2dcda724d79402f9d0cb3d910620b7a DE-627 ger DE-627 rakwb eng RC254-282 Andrew H. Wei verfasserin aut Author Correction: 6-month follow-up of VIALE-C demonstrates improved and durable efficacy in patients with untreated AML ineligible for intensive chemotherapy 2021 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Neoplasms. Tumors. Oncology. Including cancer and carcinogens Panayiotis Panayiotidis verfasserin aut Pau Montesinos verfasserin aut Kamel Laribi verfasserin aut Vladimir Ivanov verfasserin aut Inho Kim verfasserin aut Jan Novak verfasserin aut Don A. Stevens verfasserin aut Walter Fiedler verfasserin aut Maria Pagoni verfasserin aut Julie Bergeron verfasserin aut Stephen B. Ting verfasserin aut Jing-Zhou Hou verfasserin aut Achilles Anagnostopoulos verfasserin aut Andrew McDonald verfasserin aut Vidhya Murthy verfasserin aut Takahiro Yamauchi verfasserin aut Jianxiang Wang verfasserin aut Brenda Chyla verfasserin aut Yan Sun verfasserin aut Qi Jiang verfasserin aut Wellington Mendes verfasserin aut John Hayslip verfasserin aut Courtney D. DiNardo verfasserin aut In Blood Cancer Journal Nature Publishing Group, 2012 11(2021), 10, Seite 1 (DE-627)655134174 (DE-600)2600560-8 20445385 nnns volume:11 year:2021 number:10 pages:1 https://doi.org/10.1038/s41408-021-00565-6 kostenfrei https://doaj.org/article/b2dcda724d79402f9d0cb3d910620b7a kostenfrei https://doi.org/10.1038/s41408-021-00565-6 kostenfrei https://doaj.org/toc/2044-5385 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ SSG-OLC-PHA GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 11 2021 10 1
allfields_unstemmed	10.1038/s41408-021-00565-6 doi (DE-627)DOAJ076147053 (DE-599)DOAJb2dcda724d79402f9d0cb3d910620b7a DE-627 ger DE-627 rakwb eng RC254-282 Andrew H. Wei verfasserin aut Author Correction: 6-month follow-up of VIALE-C demonstrates improved and durable efficacy in patients with untreated AML ineligible for intensive chemotherapy 2021 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Neoplasms. Tumors. Oncology. Including cancer and carcinogens Panayiotis Panayiotidis verfasserin aut Pau Montesinos verfasserin aut Kamel Laribi verfasserin aut Vladimir Ivanov verfasserin aut Inho Kim verfasserin aut Jan Novak verfasserin aut Don A. Stevens verfasserin aut Walter Fiedler verfasserin aut Maria Pagoni verfasserin aut Julie Bergeron verfasserin aut Stephen B. Ting verfasserin aut Jing-Zhou Hou verfasserin aut Achilles Anagnostopoulos verfasserin aut Andrew McDonald verfasserin aut Vidhya Murthy verfasserin aut Takahiro Yamauchi verfasserin aut Jianxiang Wang verfasserin aut Brenda Chyla verfasserin aut Yan Sun verfasserin aut Qi Jiang verfasserin aut Wellington Mendes verfasserin aut John Hayslip verfasserin aut Courtney D. DiNardo verfasserin aut In Blood Cancer Journal Nature Publishing Group, 2012 11(2021), 10, Seite 1 (DE-627)655134174 (DE-600)2600560-8 20445385 nnns volume:11 year:2021 number:10 pages:1 https://doi.org/10.1038/s41408-021-00565-6 kostenfrei https://doaj.org/article/b2dcda724d79402f9d0cb3d910620b7a kostenfrei https://doi.org/10.1038/s41408-021-00565-6 kostenfrei https://doaj.org/toc/2044-5385 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ SSG-OLC-PHA GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 11 2021 10 1
allfieldsGer	10.1038/s41408-021-00565-6 doi (DE-627)DOAJ076147053 (DE-599)DOAJb2dcda724d79402f9d0cb3d910620b7a DE-627 ger DE-627 rakwb eng RC254-282 Andrew H. Wei verfasserin aut Author Correction: 6-month follow-up of VIALE-C demonstrates improved and durable efficacy in patients with untreated AML ineligible for intensive chemotherapy 2021 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Neoplasms. Tumors. Oncology. Including cancer and carcinogens Panayiotis Panayiotidis verfasserin aut Pau Montesinos verfasserin aut Kamel Laribi verfasserin aut Vladimir Ivanov verfasserin aut Inho Kim verfasserin aut Jan Novak verfasserin aut Don A. Stevens verfasserin aut Walter Fiedler verfasserin aut Maria Pagoni verfasserin aut Julie Bergeron verfasserin aut Stephen B. Ting verfasserin aut Jing-Zhou Hou verfasserin aut Achilles Anagnostopoulos verfasserin aut Andrew McDonald verfasserin aut Vidhya Murthy verfasserin aut Takahiro Yamauchi verfasserin aut Jianxiang Wang verfasserin aut Brenda Chyla verfasserin aut Yan Sun verfasserin aut Qi Jiang verfasserin aut Wellington Mendes verfasserin aut John Hayslip verfasserin aut Courtney D. DiNardo verfasserin aut In Blood Cancer Journal Nature Publishing Group, 2012 11(2021), 10, Seite 1 (DE-627)655134174 (DE-600)2600560-8 20445385 nnns volume:11 year:2021 number:10 pages:1 https://doi.org/10.1038/s41408-021-00565-6 kostenfrei https://doaj.org/article/b2dcda724d79402f9d0cb3d910620b7a kostenfrei https://doi.org/10.1038/s41408-021-00565-6 kostenfrei https://doaj.org/toc/2044-5385 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ SSG-OLC-PHA GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 11 2021 10 1
allfieldsSound	10.1038/s41408-021-00565-6 doi (DE-627)DOAJ076147053 (DE-599)DOAJb2dcda724d79402f9d0cb3d910620b7a DE-627 ger DE-627 rakwb eng RC254-282 Andrew H. Wei verfasserin aut Author Correction: 6-month follow-up of VIALE-C demonstrates improved and durable efficacy in patients with untreated AML ineligible for intensive chemotherapy 2021 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Neoplasms. Tumors. Oncology. Including cancer and carcinogens Panayiotis Panayiotidis verfasserin aut Pau Montesinos verfasserin aut Kamel Laribi verfasserin aut Vladimir Ivanov verfasserin aut Inho Kim verfasserin aut Jan Novak verfasserin aut Don A. Stevens verfasserin aut Walter Fiedler verfasserin aut Maria Pagoni verfasserin aut Julie Bergeron verfasserin aut Stephen B. Ting verfasserin aut Jing-Zhou Hou verfasserin aut Achilles Anagnostopoulos verfasserin aut Andrew McDonald verfasserin aut Vidhya Murthy verfasserin aut Takahiro Yamauchi verfasserin aut Jianxiang Wang verfasserin aut Brenda Chyla verfasserin aut Yan Sun verfasserin aut Qi Jiang verfasserin aut Wellington Mendes verfasserin aut John Hayslip verfasserin aut Courtney D. DiNardo verfasserin aut In Blood Cancer Journal Nature Publishing Group, 2012 11(2021), 10, Seite 1 (DE-627)655134174 (DE-600)2600560-8 20445385 nnns volume:11 year:2021 number:10 pages:1 https://doi.org/10.1038/s41408-021-00565-6 kostenfrei https://doaj.org/article/b2dcda724d79402f9d0cb3d910620b7a kostenfrei https://doi.org/10.1038/s41408-021-00565-6 kostenfrei https://doaj.org/toc/2044-5385 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ SSG-OLC-PHA GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 11 2021 10 1
language	English
source	In Blood Cancer Journal 11(2021), 10, Seite 1 volume:11 year:2021 number:10 pages:1
sourceStr	In Blood Cancer Journal 11(2021), 10, Seite 1 volume:11 year:2021 number:10 pages:1
format_phy_str_mv	Article
institution	findex.gbv.de
topic_facet	Neoplasms. Tumors. Oncology. Including cancer and carcinogens
isfreeaccess_bool	true
container_title	Blood Cancer Journal
authorswithroles_txt_mv	Andrew H. Wei @@aut@@ Panayiotis Panayiotidis @@aut@@ Pau Montesinos @@aut@@ Kamel Laribi @@aut@@ Vladimir Ivanov @@aut@@ Inho Kim @@aut@@ Jan Novak @@aut@@ Don A. Stevens @@aut@@ Walter Fiedler @@aut@@ Maria Pagoni @@aut@@ Julie Bergeron @@aut@@ Stephen B. Ting @@aut@@ Jing-Zhou Hou @@aut@@ Achilles Anagnostopoulos @@aut@@ Andrew McDonald @@aut@@ Vidhya Murthy @@aut@@ Takahiro Yamauchi @@aut@@ Jianxiang Wang @@aut@@ Brenda Chyla @@aut@@ Yan Sun @@aut@@ Qi Jiang @@aut@@ Wellington Mendes @@aut@@ John Hayslip @@aut@@ Courtney D. DiNardo @@aut@@
publishDateDaySort_date	2021-01-01T00:00:00Z
hierarchy_top_id	655134174
id	DOAJ076147053
language_de	englisch
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ076147053</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230503061947.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230228s2021 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1038/s41408-021-00565-6</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ076147053</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJb2dcda724d79402f9d0cb3d910620b7a</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC254-282</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Andrew H. Wei</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Author Correction: 6-month follow-up of VIALE-C demonstrates improved and durable efficacy in patients with untreated AML ineligible for intensive chemotherapy</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2021</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Neoplasms. Tumors. Oncology. Including cancer and carcinogens</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Panayiotis Panayiotidis</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Pau Montesinos</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Kamel Laribi</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Vladimir Ivanov</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Inho Kim</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Jan Novak</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Don A. Stevens</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Walter Fiedler</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Maria Pagoni</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Julie Bergeron</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Stephen B. Ting</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Jing-Zhou Hou</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Achilles Anagnostopoulos</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Andrew McDonald</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Vidhya Murthy</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Takahiro Yamauchi</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Jianxiang Wang</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Brenda Chyla</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Yan Sun</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Qi Jiang</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Wellington Mendes</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">John Hayslip</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Courtney D. DiNardo</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Blood Cancer Journal</subfield><subfield code="d">Nature Publishing Group, 2012</subfield><subfield code="g">11(2021), 10, Seite 1</subfield><subfield code="w">(DE-627)655134174</subfield><subfield code="w">(DE-600)2600560-8</subfield><subfield code="x">20445385</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:11</subfield><subfield code="g">year:2021</subfield><subfield code="g">number:10</subfield><subfield code="g">pages:1</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1038/s41408-021-00565-6</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/b2dcda724d79402f9d0cb3d910620b7a</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1038/s41408-021-00565-6</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2044-5385</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_31</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">11</subfield><subfield code="j">2021</subfield><subfield code="e">10</subfield><subfield code="h">1</subfield></datafield></record></collection>
callnumber-first	R - Medicine
author	Andrew H. Wei
spellingShingle	Andrew H. Wei misc RC254-282 misc Neoplasms. Tumors. Oncology. Including cancer and carcinogens Author Correction: 6-month follow-up of VIALE-C demonstrates improved and durable efficacy in patients with untreated AML ineligible for intensive chemotherapy
authorStr	Andrew H. Wei
ppnlink_with_tag_str_mv	@@773@@(DE-627)655134174
format	electronic Article
delete_txt_mv	keep
author_role	aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut
collection	DOAJ
remote_str	true
callnumber-label	RC254-282
illustrated	Not Illustrated
issn	20445385
topic_title	RC254-282 Author Correction: 6-month follow-up of VIALE-C demonstrates improved and durable efficacy in patients with untreated AML ineligible for intensive chemotherapy
topic	misc RC254-282 misc Neoplasms. Tumors. Oncology. Including cancer and carcinogens
topic_unstemmed	misc RC254-282 misc Neoplasms. Tumors. Oncology. Including cancer and carcinogens
topic_browse	misc RC254-282 misc Neoplasms. Tumors. Oncology. Including cancer and carcinogens
format_facet	Elektronische Aufsätze Aufsätze Elektronische Ressource
format_main_str_mv	Text Zeitschrift/Artikel
carriertype_str_mv	cr
hierarchy_parent_title	Blood Cancer Journal
hierarchy_parent_id	655134174
hierarchy_top_title	Blood Cancer Journal
isfreeaccess_txt	true
familylinks_str_mv	(DE-627)655134174 (DE-600)2600560-8
title	Author Correction: 6-month follow-up of VIALE-C demonstrates improved and durable efficacy in patients with untreated AML ineligible for intensive chemotherapy
ctrlnum	(DE-627)DOAJ076147053 (DE-599)DOAJb2dcda724d79402f9d0cb3d910620b7a
title_full	Author Correction: 6-month follow-up of VIALE-C demonstrates improved and durable efficacy in patients with untreated AML ineligible for intensive chemotherapy
author_sort	Andrew H. Wei
journal	Blood Cancer Journal
journalStr	Blood Cancer Journal
callnumber-first-code	R
lang_code	eng
isOA_bool	true
recordtype	marc
publishDateSort	2021
contenttype_str_mv	txt
container_start_page	1
author_browse	Andrew H. Wei Panayiotis Panayiotidis Pau Montesinos Kamel Laribi Vladimir Ivanov Inho Kim Jan Novak Don A. Stevens Walter Fiedler Maria Pagoni Julie Bergeron Stephen B. Ting Jing-Zhou Hou Achilles Anagnostopoulos Andrew McDonald Vidhya Murthy Takahiro Yamauchi Jianxiang Wang Brenda Chyla Yan Sun Qi Jiang Wellington Mendes John Hayslip Courtney D. DiNardo
container_volume	11
class	RC254-282
format_se	Elektronische Aufsätze
author-letter	Andrew H. Wei
doi_str_mv	10.1038/s41408-021-00565-6
author2-role	verfasserin
title_sort	author correction: 6-month follow-up of viale-c demonstrates improved and durable efficacy in patients with untreated aml ineligible for intensive chemotherapy
callnumber	RC254-282
title_auth	Author Correction: 6-month follow-up of VIALE-C demonstrates improved and durable efficacy in patients with untreated AML ineligible for intensive chemotherapy
collection_details	GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ SSG-OLC-PHA GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700
container_issue	10
title_short	Author Correction: 6-month follow-up of VIALE-C demonstrates improved and durable efficacy in patients with untreated AML ineligible for intensive chemotherapy
url	https://doi.org/10.1038/s41408-021-00565-6 https://doaj.org/article/b2dcda724d79402f9d0cb3d910620b7a https://doaj.org/toc/2044-5385
remote_bool	true
author2	Panayiotis Panayiotidis Pau Montesinos Kamel Laribi Vladimir Ivanov Inho Kim Jan Novak Don A. Stevens Walter Fiedler Maria Pagoni Julie Bergeron Stephen B. Ting Jing-Zhou Hou Achilles Anagnostopoulos Andrew McDonald Vidhya Murthy Takahiro Yamauchi Jianxiang Wang Brenda Chyla Yan Sun Qi Jiang Wellington Mendes John Hayslip Courtney D. DiNardo
author2Str	Panayiotis Panayiotidis Pau Montesinos Kamel Laribi Vladimir Ivanov Inho Kim Jan Novak Don A. Stevens Walter Fiedler Maria Pagoni Julie Bergeron Stephen B. Ting Jing-Zhou Hou Achilles Anagnostopoulos Andrew McDonald Vidhya Murthy Takahiro Yamauchi Jianxiang Wang Brenda Chyla Yan Sun Qi Jiang Wellington Mendes John Hayslip Courtney D. DiNardo
ppnlink	655134174
callnumber-subject	RC - Internal Medicine
mediatype_str_mv	c
isOA_txt	true
hochschulschrift_bool	false
doi_str	10.1038/s41408-021-00565-6
callnumber-a	RC254-282
up_date	2024-07-03T18:51:47.294Z
_version_	1803585016085610496
fullrecord_marcxml	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ076147053</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230503061947.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230228s2021 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1038/s41408-021-00565-6</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ076147053</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJb2dcda724d79402f9d0cb3d910620b7a</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC254-282</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Andrew H. Wei</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Author Correction: 6-month follow-up of VIALE-C demonstrates improved and durable efficacy in patients with untreated AML ineligible for intensive chemotherapy</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2021</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Neoplasms. Tumors. Oncology. Including cancer and carcinogens</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Panayiotis Panayiotidis</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Pau Montesinos</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Kamel Laribi</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Vladimir Ivanov</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Inho Kim</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Jan Novak</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Don A. Stevens</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Walter Fiedler</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Maria Pagoni</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Julie Bergeron</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Stephen B. Ting</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Jing-Zhou Hou</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Achilles Anagnostopoulos</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Andrew McDonald</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Vidhya Murthy</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Takahiro Yamauchi</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Jianxiang Wang</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Brenda Chyla</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Yan Sun</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Qi Jiang</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Wellington Mendes</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">John Hayslip</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Courtney D. DiNardo</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Blood Cancer Journal</subfield><subfield code="d">Nature Publishing Group, 2012</subfield><subfield code="g">11(2021), 10, Seite 1</subfield><subfield code="w">(DE-627)655134174</subfield><subfield code="w">(DE-600)2600560-8</subfield><subfield code="x">20445385</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:11</subfield><subfield code="g">year:2021</subfield><subfield code="g">number:10</subfield><subfield code="g">pages:1</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1038/s41408-021-00565-6</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/b2dcda724d79402f9d0cb3d910620b7a</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1038/s41408-021-00565-6</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2044-5385</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_31</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">11</subfield><subfield code="j">2021</subfield><subfield code="e">10</subfield><subfield code="h">1</subfield></datafield></record></collection>
score	7.4001503

Nicht das Richtige dabei?

Schreiben Sie uns!

Author Correction: 6-month follow-up of VIALE-C demonstrates improved and durable efficacy in patients with untreated AML ineligible for intensive chemotherapy

Nicht das Richtige dabei?

Zugang & Verfügbarkeit

Vorhandene Bände

Nicht das Richtige dabei?